Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|77|1|23-37

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.1, 2010-02, pp. : 23-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Utility of Neoadjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite

Adherence to Endocrine Therapy for Breast Cancer

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Extended adjuvant endocrine therapy of early breast cancer

By Chowdhury Simon   Ellis Paul  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1985-1995

Informa Healthcare

Access to resources Recommend Favorite

Optimal adjuvant endocrine therapy for early breast cancer

By Stuart-Harris Robin   Davis Alison  

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 383-398

Future Medicine

Access to resources Recommend Favorite

Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite